2019
Simultaneous determination of bisoprolol fumarate and rosuvastatin calcium in a new combined formulation by validated RP-HPLC
Abstract: A simple, specific, and precise RP-HPLC method was developed and validated for simultaneous determination of Bisoprolol fumarate (BIS) and Rosuvastatin calcium (ROS) in new formulated tablets. The developed RP-HPLC method depended on chromatographic separation using C18 column (150×4.6 mm, 0.5 μm) with mobile phase consisted of acetonitrile and 0.05 aqueous solution of orthophosphoric acid at the ratio of 65:35 % (v:v) with a flow rate of 1 mL/min and UV detection was carried out at 230 nm. Factors affecting t…
Search citation statements
Paper Sections
Select...
9
2
0
0
Citation Types
0
4
0
0
Year Published
2021
2026
Publication Types
Select...
8
2
1
Relationship
0
11
Authors
Journals
Cited by 11 publications
(4 citation statements)
References 19 publications
0
4
0
0
“…The present study envisages developing and validating the Q-absorbance UV-spectrophotometric method for simultaneously estimating BF and CLD in their tablet formulation. Determination of BF alone and in combinations with other drugs is reported in the literature by various methods, that is, UV Spectrophotometry, [6][7][8][9] HPTLC, [10][11][12] HPLC, [13][14][15][16][17][18][19] and capillary electrophoresis. [20][21][22] Furthermore, determination of CLD alone or with other drugs by HPTLC, [23][24][25][26][27][28] HPLC, [29][30][31][32][33][34] and spectrophotometry [30,[35][36][37][38][39][40][41][42][43][44][45] is reported.…”
Section: Original Articlementioning
confidence: 99%
“…The present study envisages developing and validating the Q-absorbance UV-spectrophotometric method for simultaneously estimating BF and CLD in their tablet formulation. Determination of BF alone and in combinations with other drugs is reported in the literature by various methods, that is, UV Spectrophotometry, [6][7][8][9] HPTLC, [10][11][12] HPLC, [13][14][15][16][17][18][19] and capillary electrophoresis. [20][21][22] Furthermore, determination of CLD alone or with other drugs by HPTLC, [23][24][25][26][27][28] HPLC, [29][30][31][32][33][34] and spectrophotometry [30,[35][36][37][38][39][40][41][42][43][44][45] is reported.…”
Section: Original Articlementioning
confidence: 99%
“…The developed RP-HPLC method depended on chromatographic separation using C 18 column (150 × 4.6 mm, 5 μm) with mobile phase consisting of acetonitrile and 0.05 aqueous solution of orthophosphoric acid at the ratio of 65:35 % (v:v) with a flow rate of 1 mL/min and UV detection at 230 nm [154]. HPTLC method was used for simultaneous determination of bisoprolol and hydrochlorothiazide in pharmaceutical dosage forms.…”
Section: Literature Reviewmentioning
confidence: 99%
“…An extensive literature review revealed that various analytical methods like the RP‐HPLC pharmacopoeial method [3], spectrofluorimetric method [4, 5], RP‐HPLC [6–8], UPLC [9], HPTLC [10], LC‐MS [11, 12], and HS‐GC‐FID [13] methods are reported for DPM alone, and UV [14–25], RP‐HPLC [26–45], UPLC [46–48], HPTLC [43, 44, 49–57], LC‐MS/MS [45, 58, 59], and CE [60] methods are reported for DPM with other drugs. Pharmacopoeial methods [61–63], UV [64–68], RP‐HPLC [69–72], LC‐MS [73, 74], LC‐MS/MS [75], and UPLC‐MS/MS [76] methods are reported for BF alone, and spectrofluorimetric methods [77], UV [78–85], RP‐HPLC [86–97], UPLC [98], LC‐MS/MS [99], and HPTLC [100–104] for BF with other drugs. Both drugs have been estimated individually and with other drugs, but as it is a recently approved combination, no analytical method is available for simultaneous quantification of DPM and BF.…”
Section: Introductionmentioning
confidence: 99%
